ArticleHeliyon2023
The impact of environmental regulation, Environment, Social and Government Performance, and technological innovation on enterprise resilience under a green recovery.
Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- The Life Cycle Assessment of Filamentous Fungi in Pharmaceutical Bioremediation and Wastewater Management: A Critical Review.ACS ES&T water · 2026Review
- Low-carbon economy transition, environmental policy stringency, and public health: the roles of technological development and air quality.Frontiers in public health · 2026Article
- Effect of Essential Oils and Dried Herbs on the Shelf Life of Fresh Goat Lump Cheese.Foods (Basel, Switzerland) · 2024Article
- A meta-analysis of the causal interpretation of enterprise green innovation: A structural theoretical model.Heliyon · 2024Article
- Sustaining the future: How green capabilities and digitalization drive sustainability in modern business.Heliyon · 2024Article
- Corporate governance, financial performance, and economic policy uncertainty. Evidence from emerging Asian economies.PloS one · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, the world has witnessed an alarming rise in extreme events, posing significant challenges to the survival and growth of enterprises. In response, adopting a green development strategy has emerged as an imperative for businesses to bolster their resilience. It is crucial to recognize that not all enterprises possess the same level of resilience, thereby highlighting the disparities in their ability to withstand adversity. Consequently, scholars have been fervently engaging in discussions and research to identify the most effective paths of green development, enabling enterprises to enhance their resilience and adeptly navigate through crises. This study employs questionnaires to scrutinize the influence of environmental regulation, environment social and government performance, and technological innovation on enterprise resilience by constructing structural equations that encompass both external constraints and internal corporate management. The findings demonstrate that environmental regulations can stimulate technological innovation for the purpose of promoting sustainable development, thereby bolstering enterprise resilience; By incorporating environment social and government principles into their operations, enterprises can instil a culture of environmental consciousness and proactively incentivize innovative solutions, ultimately enhancing their capacity to adapt swiftly and recover from crises; The practice of environmental regulation and the incorporation of environment social and government concepts serve as a catalyst for enterprises to engage in technological innovation, thereby promoting technological advancement and enhancing corporate resilience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.